Showing posts with label BioTech. Show all posts
Showing posts with label BioTech. Show all posts
Wednesday, August 3, 2022
Look Out for Life Sciences
After noticing a cup and handle formation in process, I initiated a position in Meridan Bioscience. The stock has since broken out and could have room to run. Let's learn more!
Monday, November 1, 2021
T-Cell Immunotherapy stock $PDSB primed to run?
In evaluating PDS Biotechnology, noting immunotherapy is considered as perhaps having the greatest area of potential for developing effective cancer drugs utilizing our own immune system, I found the company description really attractive.
Is T-Cell immunotherapy stock $PDSB primed to run?
Sunday, August 29, 2021
Subscribe to:
Posts (Atom)